The Einstein-Montefiore Institute for Clinical and Translational Research (ICTR) has evolved over the past two CTSA funding periods, embracing the broad spectrum of clinical and translational (C/T) biomedical research from T1 through T4. We have provided pathways for our clinicians and our integrated healthcare system to expand implementation science, population health, community-engaged research, and clinical trials while also encouraging basic scientists to innovate new therapeutics and diagnostics. This broad involvement with our community and investigators has allowed the CTSA to impact a wide range of research extending from drug design and improving clinical trials management, to training a new research workforce, and to using implementation science for community-engaged and healthcare research. Indeed, the ICTR?s mission?to advance research across the translational spectrum into clinical practice through its integrated infrastructure, innovative training, and institutional co-investment?has evolved in step with that of the National Center for Advancing Translational Sciences. In this application, we will 1) leverage CTSA resources with institutional assets that support state-of-the-art informatics to accelerate the transfer of discoveries to healthcare via an Evidence Generation Framework, and support regulatory streamlining, innovative analytics, and assist with all phases of C/T research; 2) develop the next generation of research workforce and teams, using novel education, training, mentoring, pilot study support, and career development resources that span translational domains; 3) expand collaborations and engagement, both with the CTSA network and other hubs, and the Bronx community and healthcare partners in an integrative paradigm with strategies developed in collaboration with community partners, investigators, and institutional leadership to improve population health; 4) advance life span, child health, and aging research across genders and special populations, by working with unique platforms for stakeholder-engaged research, patient safety and implementation science, the Montefiore Accountable Care Organization, and the New York City Practice-Based Research Network; and 5) innovate methods and processes that advance C/T sciences, and enhance quality, safety, and efficiency of C/T research. We will integrate the CTSA Trial Innovation Network into our ecosystem of multisite clinical trials, foster innovative methods for biomarker assays and biobanking for precision medicine, and leverage the CTSA Common Metrics Initiative to support our hub?s Evaluation and strategic management. Overall, the Einstein- Montefiore ICTR will fulfill NCATS?s tripartite mission to innovate, educate, and implement.

Public Health Relevance

The Einstein-Montefiore Institute for Clinical and Translational Research (ICTR) supports laboratory and clinical research investigators working to bring new treatments to the public more quickly, safely and efficiently with the overall goal of improving population health. The mission of the ICTR is also to train the next generation of clinical and translational research teams so that they develop the competencies to apply new knowledge and processes, as well as to expand collaborations with the community and healthcare partners.

National Institute of Health (NIH)
National Center for Advancing Translational Sciences (NCATS)
Linked Specialized Center Cooperative Agreement (UL1)
Project #
Application #
Study Section
Special Emphasis Panel (ZTR1)
Program Officer
Talbot, Bernard
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Albert Einstein College of Medicine
United States
Zip Code
Taneva, Ekaterina; Sinclair, Shada; Mesquita, Pedro Mm et al. (2018) Vaginal microbiome modulates topical antiretroviral drug pharmacokinetics. JCI Insight 3:
Fox, Robert J; Coffey, Christopher S; Conwit, Robin et al. (2018) Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis. N Engl J Med 379:846-855
Abramowitz, Matthew K; Hall, Charles B; Amodu, Afolarin et al. (2018) Correction: Muscle mass, BMI, and mortality among adults in the United States: A population-based cohort study. PLoS One 13:e0198318
Gasic, Daniel; Rosenschöld, Per Munck Af; Vogelius, Ivan R et al. (2018) Retrospective estimation of heart and lung doses in pediatric patients treated with spinal irradiation. Radiother Oncol 128:209-213
Sohler, Nancy L; Starrels, Joanna L; Khalid, Laila et al. (2018) Cannabis Use is Associated with Lower Odds of Prescription Opioid Analgesic Use Among HIV-Infected Individuals with Chronic Pain. Subst Use Misuse 53:1602-1607
Holtzer, Roee; George, Claudene J; Izzetoglu, Meltem et al. (2018) The effect of diabetes on prefrontal cortex activation patterns during active walking in older adults. Brain Cogn 125:14-22
Tymon-Rosario, Joan R; Miller, Eirwen M; Gressel, Gregory M et al. (2018) Association between diabetes mellitus and progression free survival in women with ovarian granulosa cell tumors. Gynecol Oncol Rep 26:94-98
Rubin, Todd G; Catenaccio, Eva; Fleysher, Roman et al. (2018) MRI-defined White Matter Microstructural Alteration Associated with Soccer Heading Is More Extensive in Women than Men. Radiology 289:478-486
Kim, Kun-Yong; Tanaka, Yoshiaki; Su, Juan et al. (2018) Uhrf1 regulates active transcriptional marks at bivalent domains in pluripotent stem cells through Setd1a. Nat Commun 9:2583
Gubbi, Sriram; Quipildor, Gabriela Farias; Barzilai, Nir et al. (2018) 40 YEARS of IGF1: IGF1: the Jekyll and Hyde of the aging brain. J Mol Endocrinol 61:T171-T185

Showing the most recent 10 out of 33 publications